Myelodysplastic Syndromes 2023: What’s New?
The Symposium brought together an international faculty of experts who presented, debated, and discussed recent advances in myelodysplastic syndromes (MDS). This summary describes the presentations, highlighting current challenges, new developments, as well as potential future approaches to improve the diagnosis and treatment of MDS.
What can MDS patients expect in the future?
Views from a patient who attended ASH 2020 Virtual
Much New Knowledge but No New Drugs
An MDS patient’s reflections on participating in the MDS Foundation’s 15th International Symposium on MDS.
The Canyon between Diagnosis and Therapy in MDS – May 8-11, 2019
A patient perspective on the MDS Foundation’s 15th International Symposium on Myelodysplastic Syndromes in Copenhagen.
MDS Foundation’s 2017 ASH Symposium – December 8th, 2018
This summary discusses recent developments in our knowledge of the immune system, the bone marrow micro-environment and the genetic evolution of MDS that are optimizing prognosis and management strategies. Intrinsic and extrinsic factors contributing to disease origin and development, as well as influencing therapeutic responses.
MDS Foundation’s 14th International Symposium on Myelodysplastic Syndromes – May 3-6, 2017
This guide includes material related to clinical aspects of MDS diagnosis, prognosis, and management as well as the newest data in MDS basic and translational research. The MDS Foundation selected discussions we feel they are the most relevant and important for patients who are currently living with MDS.
